aTyr Pharma Obtains $23,000,000 Series C Financing
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=37565c00-e646-4307-a248-1c7a2998870c&Preview=1
Date 10/26/2010
Company Name aTyr Pharma
Mailing Address 3565 General Atomics Court San Diego, CA 92121
Company Description We have developed proprietary methods for discovering Physiocrines, extracellular proteins that are derived from the tRNA synthetase family of enzymes, and which were predominantly overlooked by other genomic and secretome discovery efforts.
Proceeds Purposes Proceeds will be used to accelerate the development of aTyr’s preclinical pipeline and advance physiocrine drug candidates into clinical trials.